Physician profile
David W Spinks
NPI 1972544500
$1,880.23
in general payments reported to CMS, 2019-2025
19 companies · $46.27 in 2025
The $46.27 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $512 · 2020: $227 · 2021: $503 · 2022: $298 · 2023: $144 · 2024: $150 · 2025: $46.27.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $340.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $340.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $313.16 | 2021-2023 | Vraylar |
| Astellas Pharma US INC | $266.67 | 2019-2021 | |
| Astrazeneca Pharmaceuticals Lp | $247.90 | 2019-2024 | Farxiga, Airsupra |
| Sunovion Pharmaceuticals INC. | $191.05 | 2021-2022 | |
| Boston Scientific Corporation | $149.02 | 2019-2023 | |
| Allergan, INC. | $126.78 | 2019-2020 | |
| Lilly USA, LLC | $115.09 | 2019-2024 | Mounjaro, Zepbound, Jardiance |
| Sumitomo Pharma America, INC. | $84.13 | 2023-2025 | Gemtesa |
| Novartis Pharmaceuticals Corporation | $79.63 | 2019-2020 | |
| Medtronic Vascular, INC. | $54.99 | 2019 | |
| Glaxosmithkline, LLC. | $50.75 | 2020-2024 | Trelegy Ellipta |
| Pfizer INC. | $34.76 | 2019-2020 | |
| Kowa Pharmaceuticals America, INC. | $34.45 | 2022 | |
| Nestle Healthcare Nutrition INC. | $28.43 | 2021 | |
| Amgen INC. | $25.04 | 2025 | Repatha |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Antares Pharma, INC. | $23.00 | 2022 | |
| Cequr Corporation | $20.12 | 2024 | Cequr Simplicity |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $18.20 | 2019 | |
| Exact Sciences Corporation | $17.06 | 2024 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Spinks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.